Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Mar 9, 2024
Open Peer Review Period: Mar 8, 2024 - May 3, 2024
Date Accepted: Apr 14, 2025
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Evaluating a Mobile Digital Therapeutic for Vasomotor and Behavioral Health Symptoms Among Women in Midlife: Randomized Controlled Trial

Duffecy J, Rehman A, Gorman S, Huang YL, Klumpp H

Evaluating a Mobile Digital Therapeutic for Vasomotor and Behavioral Health Symptoms Among Women in Midlife: Randomized Controlled Trial

JMIR Mhealth Uhealth 2025;13:e58204

DOI: 10.2196/58204

PMID: 40526898

PMCID: 12187029

Evaluating a Mobile Digital Therapeutic for Vasomotor and Behavioral Health Symptoms Among Women in Midlife: Randomized Control Trial

  • Jennifer Duffecy; 
  • Arfa Rehman; 
  • Scott Gorman; 
  • Yong Lin Huang; 
  • Heide Klumpp

ABSTRACT

Background:

In midlife, many women experience significant physical and psychological symptoms associated with menopause, impacting their well-being and quality of life. While behavioral interventions are effective in alleviating these symptoms, access can be challenging. Digital technology, especially smartphones, offers a promising avenue for delivering self-management interventions for menopausal symptoms, but research in this domain remains limited.

Objective:

This study aimed to evaluate the efficacy of a novel digital care program, the Caria App, in reducing vasomotor and behavioral health symptoms among women experiencing menopause.

Methods:

The study enrolled 149 women for a randomized control trial, with 112 in the treatment group and 37 in the control group. Enrolled participants had problematic vasomotor symptoms and at least one elevated behavioral health symptom (depression, anxiety, or sleep issues). Participants were recruited online and randomized into a treatment group, receiving access to the self-guided Caria App for six weeks, and a control group, provided with online educational materials. The Caria app utilizes approaches such as CBT, mindfulness, and mobility for menopausal symptom management. Web-based self-reported assessments using the Hot Flush Rating Scale, PHQ8, GAD7, and PSQI were conducted at baseline, 3 weeks, and 6 weeks.

Results:

At 6 weeks, the treatment group showed significant improvements in hot flush distress (p<.001), depression (p<.001), and sleep quality (p=.001), while the control group showed no significant changes. Specifically, for those in the treatment group, distress from hot flashes decreased by 17.1%, depression symptoms decreased by 12.3%, and sleep problems decreased by 5.9%. The depression effect size was comparable to therapist-delivered interventions for depression in similar mildly distressed populations. The control group experienced improvement in hot flash symptoms and anxiety in the first 3 weeks of the study. However, those who used Caria showed additional improvement in hot flash distress and depression in the second half of the intervention (3 weeks - 6 weeks) while there was no change in the control group. Those with elevated anxiety symptoms who used Caria also showed a decrease in symptoms, but so did those in the control group. Engagement with the Caria app was high, with an average of 53.2 logins over 6 weeks.

Conclusions:

The findings of this study highlight the potential of digital interventions for mitigating vasomotor and behavioral health symptoms associated with menopause. The significant improvements observed in the intervention group underscore the app's effectiveness in providing relief from some of the most challenging aspects of menopause. This study contributes to the growing body of evidence supporting digital health interventions in managing menopausal symptoms, presenting a promising avenue for accessible and scalable solutions for women in midlife. Clinical Trial: ClinicalTrials.gov NCT04882982


 Citation

Please cite as:

Duffecy J, Rehman A, Gorman S, Huang YL, Klumpp H

Evaluating a Mobile Digital Therapeutic for Vasomotor and Behavioral Health Symptoms Among Women in Midlife: Randomized Controlled Trial

JMIR Mhealth Uhealth 2025;13:e58204

DOI: 10.2196/58204

PMID: 40526898

PMCID: 12187029

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.